Center of Metabolic Disease, S.M. Goretti Hospital, Latina, Italy.
Unit of Metabolic Bone and Thyroid Disorders, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
Rev Endocr Metab Disord. 2022 Oct;23(5):1051-1061. doi: 10.1007/s11154-022-09743-8. Epub 2022 Jun 29.
Several studies have showed good/excellent results of thermal-ablation (TA) to reduce volume of benign thyroid nodule (TN). Nevertheless, no systematic review has reported information about clinical achievements with TA. Being the latter of high interest, this systematic review was undertaken to achieve high evidence about the efficacy of TA in reducing TN-related symptoms and cosmetic concerns. Radiofrequency (RFA) and laser (LA) therapies were considered. A comprehensive literature search of online databases was performed on January 2022 looking for studies reporting clinical results obtained by RFA or LA in terms of VAS (namely, Visual Analogic Scale) and cosmetic concerns. Initially, 318 records were found and 14 were finally included in the meta-analysis. VAS data were available in all RFA studies and the pooled mean reduction was of 3.09 points with significant heterogeneity. Cosmetic score data were available in 11 RFA studies and the pooled mean reduction was of 1.45 with significant heterogeneity. Regarding LA studies, 4 series reported VAS data and the pooled mean reduction was of 2.61 points with significant heterogeneity. The analysis of LA data about cosmetic concerns was not performed due to data paucity. Importantly, heterogeneities were not explained by meta-regression analyses using several covariates (i.e., baseline TN volume, follow-up duration, volume reduction rate). This systematic review showed that clinical data about TN TA efficacy are sparse and affected by high unexplained inconsistency. International societies should give indication about how we should clinically select and evaluate patients undergoing TN TA.
多项研究表明,热消融(TA)可有效缩小良性甲状腺结节(TN)体积,效果良好/极佳。然而,目前尚无系统评价汇总 TA 治疗 TN 的临床疗效。鉴于后者具有较高的研究价值,本系统评价旨在为 TA 治疗 TN 相关症状和美容问题的疗效提供高质量证据。本研究纳入射频消融(RFA)和激光消融(LA)两种疗法。于 2022 年 1 月对在线数据库进行全面的文献检索,查找 RFA 或 LA 治疗 TN 时通过视觉模拟评分(VAS)和美容问题评估临床疗效的相关研究。最初共检索到 318 篇文献,最终纳入 14 篇进行荟萃分析。所有 RFA 研究均提供 VAS 数据,合并后的平均降低幅度为 3.09 分,异质性显著。11 项 RFA 研究提供美容评分数据,合并后的平均降低幅度为 1.45 分,异质性显著。关于 LA 研究,4 项系列研究报道了 VAS 数据,合并后的平均降低幅度为 2.61 分,异质性显著。由于数据缺乏,无法对 LA 研究的美容问题数据进行分析。重要的是,使用多种协变量(即基线 TN 体积、随访时间、体积缩小率)进行荟萃回归分析无法解释异质性。本系统评价表明,目前关于 TN TA 疗效的临床数据较为匮乏,且受高度无法解释的异质性影响。国际相关协会应明确指出我们应如何选择和评估接受 TN TA 的患者。